An FDA panel spread misinformation about SSRI use in pregnancy, alarming doctors

Doctors are criticizing a recent expert panel organized by the U.S. Food and Drug Administration that questioned the safety of taking antidepressants during pregnancy.

A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy — drawing ire from doctors who say SSRIs are a crucial treatment option for women with perinatal depression.

(Image credit: Mykola Sosiukin)